Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol

Heart

Volumn 89, Issue 5, 2003, Pages 527-530

  Ferreira, I ^a   Dos, L ^a   Tornos, P ^a   Nicolau, I ^a   Permanyer Miralda, G ^a   Soler Soler, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ENOXAPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; COHORT ANALYSIS; DRUG EFFECT; DRUG SAFETY; EXPERIENCE; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOEMBOLISM;

EID: 0037408338     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.5.527     Document Type: Article

References (17)

1. Shapira Y, Vaturi M, Sagie A. Anticoagulation management of patients with mechanical prosthetic valves undergoing noncardiac surgery: indications and unresolved issues. J Heart Valve Dis 2001;10:380-7.
2. Bonow RO, Carabello B, de Leon AC Jr, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease). Circulation 1998;98:1949-84.
3. Meschengieser SS, Carlos GF, Santarelli MT, et al. Low-intensity oral anticoagulation plus lowdose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg 1997;113:910-6.
4. Stein PD, Alpert JS, Bussey HI, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001;119:220S-7S.
5. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest 2001;119:22S-38S.
6. Montalescot G, Polle V, Collet J, et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000;101:1083-6.
7. Collet J, Montalescot G, Choussat R, et al. Enoxaparin in unstable patients with renal failure. Int J Cardiol 2001;80:81-2.
8. Spandorfer JM, Lynch S, Weitz HH, et al. Use of enoxaparine for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999;84:478-80.
9. Gohlke-Bärwolf C. Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery. Heart 2000;84:567-72.
10. Carrel TP, Klingenmann W, Mohacsi PJ, et al. Preoperative bleeding and thromboembolic risk durtin non-cardiac surgery in patients with mechanical prosthectic heart valves: an institutional review. J Heart Valve Dis 1999;8:392-8.
11. Galla JM, Fuhs BE. Outpatients anticoagulation protocol for mechanical valve recipients undergoing non-cardiac surgery [abstract]. J Am Coll Cardiol 2000;35(suppl A):531.
12. Ferreira IJ, Dos L, Tornos MP, et al. Is low-molecular-weight heparin a safe alternative to unfractionated heparin in patients with prosthetic mechanical heart valves who must interrupt antithrombotic therapy? [abstract]. Eur Heart J 2000;21(suppl):301.
13. Johnson J, Turpie AGG. Temporary discontinuation of oral anticoagulants: role of low molecular weight heparin [abstract]. Thromb Haemost 2001;86(suppl):P2323.
14. Tinmouth A, Kovacs MJ, Cruickshank M, et al. Outpatient peri-operative and peri-procedure treatment with dalteparin for chronically anticoagulated patients at high risk for thromboembolic complications. Thromb Haemost 1999;82(suppl):662.
15. Carrel TP, Klingenmann W, Mohacsi PJ, et al. Preoperative bleeding and thromboembolic risk durtin non-cardioc surgery in patients with mechanical prosthectic heart valves: an institutional review. J Heart Valve Dis 1999;8:392-8.
16. Butchart EG, Bodnar E, eds. Thrombosis, embolism and bleeding. London: ICR Publishers, 1992:293-31.
17. Jovanovic B, Levy P. A look at the rule of three. Am Stat 1997;51:2, 137-9.